Navigation Links
Generex Provides Corporate Update
Date:8/2/2011

torical or current facts.  Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not.  Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement.  No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements.  Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.  Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials.  Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials or when it will obtain ultimate regulatory approval by a particular regulatory agency.  Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.


'/>"/>
SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 Mallinckrodt ... global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held ... into a definitive agreement under which a subsidiary of ... Dearborn -led investor group in a transaction valued at ... closing conditions, the parties expect the transaction to be ...
(Date:3/5/2015)... 5, 2015 Hitachi Medical ... of OASIS *    at ECR 2015 - ... will set a benchmark for patient-centric care. The new ... delays whilst optimizing workflow management and costs. OASIS demonstrates ... safety for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and ... the addition of Jain PharmaBiotech,s new report ... to their offering. This ... clinical specialty, aimed at improving patient care by ... adjust the dose of drugs for improving outcome. ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024 2
... Israel, May 17, 2011 InspireMD, Inc. (OTC ... MGuard™ mesh protective stent system, today announced that it has ... 31, 2011 with the U.S. Securities and Exchange Commission. The ... Fiscal Year-to-Date Highlights During March ...
... DALLAS and NEW YORK, May 17, 2011 ... a biopharmaceutical company leveraging its proprietary drug-delivery platforms to ... announced that it had made significant progress with the ... oncology communities.   MuGard is a novel, ready-to-use mucoadhesive ...
Cached Medicine Technology:InspireMD Announces Year-to-Date 2011 Progress 2InspireMD Announces Year-to-Date 2011 Progress 3InspireMD Announces Year-to-Date 2011 Progress 4InspireMD Announces Year-to-Date 2011 Progress 5Access Pharmaceuticals Provides Update on MuGard Commercial Activities 2Access Pharmaceuticals Provides Update on MuGard Commercial Activities 3Access Pharmaceuticals Provides Update on MuGard Commercial Activities 4Access Pharmaceuticals Provides Update on MuGard Commercial Activities 5Access Pharmaceuticals Provides Update on MuGard Commercial Activities 6
(Date:3/5/2015)... Creek, Michigan (PRWEB) March 05, 2015 ... the opportunity to shatter myths about drug and alcohol ... Recovery has released a Fact Sheet with information on ... abuse. Launched in 2010 by the National Institute on ... drugs and alcohol aims to counteract the illusions that ...
(Date:3/5/2015)... 05, 2015 Califia Farms , ... at Natural Products Expo West that its popular ready-to-drink ... percent soy and dairy free. Califia Farms Vegan Protein ... and are packed with six grams of an innovative ... fiber, B vitamins and magnesium. , Protein is an ...
(Date:3/5/2015)... Supply & Demand Chain Executive Magazine has officially ... in the supply chain industry, and we are excited ... were included on this year’s list! Russ King and ... to their hard work, their commitment to excellence, and ... client needs and challenges. , Russ and ...
(Date:3/5/2015)... 05, 2015 As a result ... review of Clearstream, LLC ’s products, services ... MediDefense line of products—led by their mPulse Hand ... Partner Program. , The AAPA—which represents a profession ... medical and surgical specialties in the U.S.—advocates and ...
(Date:3/5/2015)... The Journal of Child and ... special issue devoted entirely to scientific studies ... Autoimmune Neuropsychiatric Disorders Associated with Streptococci) and PANS ... by infections such as strep throat, walking pneumonia, ... the child's brain. This inflammation causes a sudden, ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3
... 10 The National Council for,Community Behavioral Healthcare ... for persons with mental illness., Yesterday the ... will phase out Medicare,s higher copays for mental ... physical healthcare,services. Since its inception in 1965, Medicare ...
... of Medicine program that partners with Purdue University to ... national recognition with a prestigious grant from the National ... students receive the both degrees in seven to eight ... Training Program award from the NIH, one of only ...
... resident Aisa,Perera, 42, was sentenced today to 30 months ... to defraud the Medicare program, Acting Assistant,Attorney General Matthew ... Acosta of the Southern District of Florida announced., ... the Southern,District of Florida by Judge Federico A. Moreno. ...
... changed, study says , , THURSDAY, July 10 (HealthDay News) -- ... increasing sharply among younger women in the United States, but ... "These findings are important, because they suggest that public education ... from sun tanning do not appear to have resulted in ...
... is a,statement by Mark J. Feldman, DMD, President, ... percent of the U.S. population now receives,optimally fluoridated ... from the Centers for Disease,Control and Prevention about ... fluoridated water. We know from years of experience ...
... Assistance Program from the Patient Advocate,Foundation and the ... Pay Medical Bills When Diagnosed with a Chronic,Debilitating ... 10 The Patient,Advocate Foundation (PAF) - a ... tens of thousands of patients every year,who face ...
Cached Medicine News:Health News:New Medicare Law Removes Barriers to Mental Health Treatment 2Health News:NIH grant to strengthen IU and Purdue program to educate physician-scientists 2Health News:HIV Infusion Clinic Administrator Sentenced to 30 Months in Prison For Health Care Fraud 2Health News:HIV Infusion Clinic Administrator Sentenced to 30 Months in Prison For Health Care Fraud 3Health News:Melanoma Rates Soar Among Younger Women 2Health News:Melanoma Rates Soar Among Younger Women 3Health News:1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP) 2Health News:1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP) 3
ScanGel® Incubator...
... The ID-Micro Typing System™ (ID-MTS) ... a broad range of blood ... antibody screening and identification, ABO ... compatibility testing, reverse serum grouping ...
... 120 Mini-Vertical Gel System simplifies the process of ... format. It is able to run four gels ... To maximize utility and throughput, the 120 mini-vertical ... gels (W x L) at one time. The ...
... High-throughput protein electrophoresis system is an ... proteins via western blotting or in ... self-contained pre-cast gels that include a ... inside a disposable UV-transparent cassette; Mother ...
Medicine Products: